Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1946

1.

Rational design of novel amphipathic antimicrobial peptides focused on the distribution of cationic amino acid residues.

Misawa T, Goto C, Shibata N, Hirano M, Kikuchi Y, Naito M, Demizu Y.

Medchemcomm. 2019 Apr 4;10(6):896-900. doi: 10.1039/c9md00166b. eCollection 2019 Jun 1.

PMID:
31303986
2.

Pathological Findings in Male Patients With Anti-N-methyl-d-Aspartate Receptor Encephalitis.

Hirano M, Itoh T, Fujimura H, Inoue K, Samukawa M, Nose K, Sakamoto H, Maekura S, Ueno S, Satou T, Nishioka T, Kusunoki S, Nakamura Y.

J Neuropathol Exp Neurol. 2019 May 31. pii: nlz052. doi: 10.1093/jnen/nlz052. [Epub ahead of print]

PMID:
31282957
3.

Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens.

Hirano M, Iritani S, Fujishiro H, Torii Y, Habuchi C, Sekiguchi H, Yoshida M, Ozaki N.

Neuropathology. 2019 Jul 2. doi: 10.1111/neup.12578. [Epub ahead of print]

PMID:
31264738
4.

Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.

Inami H, Shishikura JI, Yasunaga T, Hirano M, Kimura T, Yamashita H, Ohno K, Sakamoto S.

Chem Pharm Bull (Tokyo). 2019;67(7):699-706. doi: 10.1248/cpb.c18-00977.

5.

In vitro assessment of effects of persistent organic pollutants on the transactivation of estrogen receptor α and β (ERα and ERβ) from the Baikal seal (Pusa sibirica).

Yoshinouchi Y, Shimizu S, Lee JS, Hirano M, Suzuki KT, Kim EY, Iwata H.

Ecotoxicol Environ Saf. 2019 Oct 15;181:463-471. doi: 10.1016/j.ecoenv.2019.06.033. Epub 2019 Jun 19.

PMID:
31228822
6.

Different characteristics of postoperative atrial tachyarrhythmias between congenital and non-congenital heart disease.

Kondo M, Fukuda K, Wakayama Y, Nakano M, Hasebe Y, Satake H, Segawa M, Hirano M, Shimokawa H.

J Interv Card Electrophysiol. 2019 Jun 13. doi: 10.1007/s10840-019-00575-2. [Epub ahead of print]

PMID:
31197584
7.

Aberrant Transcriptional Regulation of Super-enhancers by RET Finger Protein-histone Deacetylase 1 Complex in Glioblastoma: Chemoresistance to Temozolomide.

Natsume A, Hirano M, Ranjit M, Aoki K, Wakabayashi T.

Neurol Med Chir (Tokyo). 2019 Jun 7. doi: 10.2176/nmc.ra.2019-0049. [Epub ahead of print]

8.

Human aging DNA methylation signatures are conserved but accelerated in cultured fibroblasts.

Sturm G, Cardenas A, Bind MA, Horvath S, Wang S, Wang Y, Hägg S, Hirano M, Picard M.

Epigenetics. 2019 Jun 12:1-16. doi: 10.1080/15592294.2019.1626651. [Epub ahead of print]

PMID:
31156022
9.

EN FACE IMAGE-BASED ANALYSIS OF RETINAL TRACTION CAUSED BY EPIRETINAL MEMBRANE AND ITS RELATIONSHIP WITH VISUAL FUNCTIONS.

Hirano M, Morizane Y, Kanzaki Y, Kimura S, Hosokawa M, Shiode Y, Doi S, Toshima S, Takahashi K, Hosogi M, Fujiwara A, Takasu I, Shiraga F.

Retina. 2019 May 23. doi: 10.1097/IAE.0000000000002569. [Epub ahead of print]

PMID:
31136461
10.

Involvement of different receptor subtypes in prostaglandin E2-induced contraction and relaxation in the lower esophageal sphincter and esophageal body.

Bai X, Ihara E, Otsuka Y, Tsuruta S, Hirano K, Tanaka Y, Ogino H, Hirano M, Chinen T, Akiho H, Nakamura K, Oda Y, Ogawa Y.

Eur J Pharmacol. 2019 Aug 15;857:172405. doi: 10.1016/j.ejphar.2019.172405. Epub 2019 May 22.

PMID:
31128092
11.

Deoxynucleoside Therapy for Thymidine Kinase 2-Deficient Myopathy.

Domínguez-González C, Madruga-Garrido M, Mavillard F, Garone C, Aguirre-Rodríguez FJ, Donati MA, Kleinsteuber K, Martí I, Martín-Hernández E, Morealejo-Aycinena JP, Munell F, Nascimento A, Kalko SG, Sardina MD, Álvarez Del Vayo C, Serrano O, Long Y, Tu Y, Levin B, Thompson JLP, Engelstad K, Uddin J, Torres-Torronteras J, Jimenez-Mallebrera C, Martí R, Paradas C, Hirano M.

Ann Neurol. 2019 Aug;86(2):293-303. doi: 10.1002/ana.25506. Epub 2019 Jun 17.

PMID:
31125140
12.

Neurocognitive and functional outcomes in patients with diffuse frontal lower-grade gliomas undergoing intraoperative awake brain mapping.

Motomura K, Chalise L, Ohka F, Aoki K, Tanahashi K, Hirano M, Nishikawa T, Yamaguchi J, Shimizu H, Wakabayashi T, Natsume A.

J Neurosurg. 2019 May 17:1-9. doi: 10.3171/2019.3.JNS19211. [Epub ahead of print]

PMID:
31100731
13.

Age Affects Clinical Management after Noncurative Endoscopic Submucosal Dissection for Early Gastric Cancer.

Esaki M, Hatta W, Shimosegawa T, Oyama T, Kawata N, Takahashi A, Oka S, Hoteya S, Nakagawa M, Hirano M, Matsuda M, Ohnita K, Shimoda R, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Aoyagi H, Gotoda T.

Dig Dis. 2019 May 16:1-11. doi: 10.1159/000499538. [Epub ahead of print]

PMID:
31096243
14.

Mutant-selective irreversible EGFR inhibitor, naquotinib, inhibits tumor growth in NSCLC models with EGFR activating mutations, T790M mutation and AXL overexpression.

Tanaka H, Sakagami H, Kaneko N, Konagai S, Yamamoto H, Matsuya T, Yuri M, Yamanaka Y, Mori M, Takeuchi M, Koshio H, Hirano M, Kuromitsu S.

Mol Cancer Ther. 2019 May 15. pii: molcanther.0976.2018. doi: 10.1158/1535-7163.MCT-18-0976. [Epub ahead of print]

PMID:
31092564
15.

The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.

Rodríguez Cruz PM, Cossins J, Estephan EP, Munell F, Selby K, Hirano M, Maroofin R, Mehrjardi MYV, Chow G, Carr A, Manzur A, Robb S, Munot P, Wei Liu W, Banka S, Fraser H, De Goede C, Zanoteli E, Conti Reed U, Sage A, Gratacos M, Macaya A, Dusl M, Senderek J, Töpf A, Hofer M, Knight R, Ramdas S, Jayawant S, Lochmüller H, Palace J, Beeson D.

Brain. 2019 Jun 1;142(6):1547-1560. doi: 10.1093/brain/awz107.

PMID:
31081514
16.

Late-onset thymidine kinase 2 deficiency: a review of 18 cases.

Domínguez-González C, Hernández-Laín A, Rivas E, Hernández-Voth A, Sayas Catalán J, Fernández-Torrón R, Fuiza-Luces C, García García J, Morís G, Olivé M, Miralles F, Díaz-Manera J, Caballero C, Méndez-Ferrer B, Martí R, García Arumi E, Badosa MC, Esteban J, Jimenez-Mallebrera C, Encinar AB, Arenas J, Hirano M, Martin MÁ, Paradas C.

Orphanet J Rare Dis. 2019 May 6;14(1):100. doi: 10.1186/s13023-019-1071-z.

17.

A case of pancreatic pseudocysts accompanied by infection, pseudoaneurysm ruptures, and pseudocystocolonic fistulae.

Sato K, Takahashi K, Aruga Y, Yamazaki F, Kumaki D, Yamakawa M, Hirano M, Funakoshi K, Terai S.

Clin J Gastroenterol. 2019 Apr 23. doi: 10.1007/s12328-019-00986-8. [Epub ahead of print]

PMID:
31016682
18.

A case of functioning gonadotroph adenoma in a reproductive aged woman.

Hirano M, Wada-Hiraike O, Miyamamoto Y, Yamada S, Fujii T, Osuga Y.

Endocr J. 2019 Apr 19. doi: 10.1507/endocrj.EJ19-0066. [Epub ahead of print]

19.

HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action.

Imai Y, Hirano M, Kobayashi M, Futami M, Tojo A.

Cancers (Basel). 2019 Apr 4;11(4). pii: E475. doi: 10.3390/cancers11040475. Review.

20.

Mothers' challenges with the parental control of 3-year-old children in Japan: A qualitative study.

Onishi R, Saeki K, Hirano M.

Child Care Health Dev. 2019 Jul;45(4):531-539. doi: 10.1111/cch.12666. Epub 2019 May 10.

PMID:
30983020
21.

A Case of Thoracic Endovascular Aortic Repair Using Carotid Access with Axillary-Carotid Bypass for Descending Aortic Aneurysm in a Patient with Aortoiliac Occlusive Disease.

Asano S, Hayashida N, Shibata Y, Koizumi S, Ito T, Ikeuchi H, Hasegawa H, Abe S, Kabasawa M, Hirose N, Ohba M, Hirano M, Matsuo K, Murayama H.

Ann Vasc Dis. 2019 Mar 25;12(1):105-108. doi: 10.3400/avd.cr.18-00143.

22.

Physiological Properties of Photoautotrophic Microalgae and Cyanobacteria Relevant to Industrial Biomass Production.

Tsuzuki M, Okada K, Isoda H, Hirano M, Odaka T, Saijo H, Aruga R, Miyauchi H, Fujiwara S.

Mar Biotechnol (NY). 2019 Jun;21(3):406-415. doi: 10.1007/s10126-019-09890-1. Epub 2019 Mar 29.

PMID:
30927152
23.

Prognostic Factors of Malignant Peritoneal Mesothelioma Experienced in Japanese Peritoneal Metastasis Center.

Yonemura Y, Canbay E, Wakama S, Sako S, Ishibashi H, Hirano M, Motoi S, Mizumoto A, Takao N, Ichinose M, Noguchi K, Liu Y, Fushida S.

Gan To Kagaku Ryoho. 2019 Feb;46(2):395-399.

PMID:
30914572
24.

Analysis of Treatment Failure after Complete Cytoreductive Surgery for Peritoneal Metastasis from Appendiceal Mucinous Neoplasm at a Japanese High Volume Center for Peritoneal Surface Malignancy.

Yonemura Y, Canbay E, Wakama S, Sako S, Ishibashi H, Hirano M, Motoi S, Mizumoto A, Takao N, Ichinose M, Noguchi K, Liu Y, Fushida S, Li Y.

Gan To Kagaku Ryoho. 2019 Feb;46(2):251-258.

PMID:
30914528
25.

The Alpha-1-Antitrypsin Promoter Improves the Efficacy of an AAV Vector for the Treatment of MNGIE.

Cabrera-Pérez R, Vila-Julià F, Hirano M, Mingozzi F, Torres-Torronteras J, Martí R.

Hum Gene Ther. 2019 Apr 24. doi: 10.1089/hum.2018.217. [Epub ahead of print]

PMID:
30900470
26.

Effect of Awareness and Habits of Oral Care on Life Satisfaction.

Hirano M, Imai H, Oya M.

Oral Health Prev Dent. 2019;17(2):131-138. doi: 10.3290/j.ohpd.a42204.

PMID:
30874253
27.

Cardiac Lymphatic Dysfunction Causes Drug-Eluting Stent-Induced Coronary Hyperconstricting Responses in Pigs In Vivo.

Amamizu H, Matsumoto Y, Morosawa S, Ohyama K, Uzuka H, Hirano M, Nishimiya K, Gokon Y, Watanabe-Asaka T, Hayashi M, Miyata S, Kamei T, Kawai Y, Shimokawa H.

Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):741-753. doi: 10.1161/ATVBAHA.119.312396.

PMID:
30816801
28.

Correction to: Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.

Sakurai K, Suda H, Fujie S, Takeichi T, Okuda A, Murao T, Hasuda K, Hirano M, Ito K, Tsuruta K, Hattori M.

Dig Dis Sci. 2019 Jun;64(6):1724. doi: 10.1007/s10620-019-5464-6.

PMID:
30815827
29.

Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma.

Ranjit M, Hirano M, Aoki K, Okuno Y, Ohka F, Yamamichi A, Kato A, Maeda S, Motomura K, Matsuo K, Enomoto A, Ino Y, Todo T, Takahashi M, Wakabayashi T, Kato T, Natsume A.

Cell Rep. 2019 Feb 26;26(9):2274-2281.e5. doi: 10.1016/j.celrep.2019.01.109.

30.

Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysis.

Dohi O, Hatta W, Gotoda T, Naito Y, Oyama T, Kawata N, Takahashi A, Oka S, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M, Ohnita K, Shimoda R, Yoshida M, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Aoyagi H, Shimosegawa T.

Surg Endosc. 2019 Feb 25. doi: 10.1007/s00464-019-06710-4. [Epub ahead of print]

PMID:
30805782
31.

BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress.

Fernando TM, Marullo R, Pera Gresely B, Phillip JM, Yang SN, Lundell-Smith G, Torregroza I, Ahn H, Evans T, Győrffy B, Privé GG, Hirano M, Melnick AM, Cerchietti L.

Cancer Discov. 2019 May;9(5):662-679. doi: 10.1158/2159-8290.CD-17-1444. Epub 2019 Feb 18.

PMID:
30777872
32.

Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary.

Akino N, Wada-Hiraike O, Isono W, Terao H, Honjo H, Miyamoto Y, Tanikawa M, Sone K, Hirano M, Harada M, Hirata T, Hirota Y, Koga K, Oda K, Fujii T, Osuga Y.

Reprod Biol Endocrinol. 2019 Feb 13;17(1):23. doi: 10.1186/s12958-019-0466-y.

33.

Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.

Nakayama T, Eda M, Hirano M, Goto W.

Hum Vaccin Immunother. 2019;15(5):1139-1144. doi: 10.1080/21645515.2019.1578591. Epub 2019 Apr 22.

34.

In Vitro and In Silico Evaluations of Binding Affinities of Perfluoroalkyl Substances to Baikal Seal and Human Peroxisome Proliferator-Activated Receptor α.

Ishibashi H, Hirano M, Kim EY, Iwata H.

Environ Sci Technol. 2019 Feb 19;53(4):2181-2188. doi: 10.1021/acs.est.8b07273. Epub 2019 Jan 31.

PMID:
30649875
35.

ADVERSE EFFECT OF MACULAR INTRARETINAL HEMORRHAGE ON THE PROGNOSIS OF SUBMACULAR HEMORRHAGE DUE TO RETINAL ARTERIAL MACROANEURYSM RUPTURE.

Doi S, Kimura S, Morizane Y, Hosokawa MM, Shiode Y, Hirano M, Toshima S, Takahashi K, Hosogi M, Fujiwara A, Okanouchi T, Inoue Y, Shiraga F.

Retina. 2019 Jan 14. doi: 10.1097/IAE.0000000000002460. [Epub ahead of print]

PMID:
30649079
36.

Development of a Shock-Wave Catheter Ablation System for Ventricular Tachyarrhythmias: Validation Study in Pigs In Vivo.

Morosawa S, Yamamoto H, Hirano M, Amamizu H, Uzuka H, Ohyama K, Hasebe Y, Nakano M, Fukuda K, Takayama K, Shimokawa H.

J Am Heart Assoc. 2019 Jan 22;8(2):e011038. doi: 10.1161/JAHA.118.011038.

37.

The influence of subretinal injection pressure on the microstructure of the monkey retina.

Takahashi K, Morizane Y, Hisatomi T, Tachibana T, Kimura S, Hosokawa MM, Shiode Y, Hirano M, Doi S, Toshima S, Araki R, Matsumae H, Kanzaki Y, Hosogi M, Yoshida A, Sonoda KH, Shiraga F.

PLoS One. 2018 Dec 31;13(12):e0209996. doi: 10.1371/journal.pone.0209996. eCollection 2018.

38.

Nested Polymerase Chain Reaction with Specific Primers for Mucorales in the Serum of Patients with Hematological Malignancies.

Hirano M, Ota Y, Koibuchi T, Takei T, Takeda R, Kawamata T, Yokoyama K, Uchimaru K, Yotsuyanagi H, Imai Y, Tojo A.

Jpn J Infect Dis. 2019 May 23;72(3):196-198. doi: 10.7883/yoken.JJID.2018.379. Epub 2018 Dec 25.

39.

Electrochromism of Ferrocene- and Viologen-Based Redox-Active Ionic Liquids Composite.

Tahara H, Uranaka K, Hirano M, Ikeda T, Sagara T, Murakami H.

ACS Appl Mater Interfaces. 2019 Jan 9;11(1):1-6. doi: 10.1021/acsami.8b16410. Epub 2018 Dec 27.

PMID:
30582681
40.

The novel de novo mutation of KIF1A gene as the cause for Spastic paraplegia 30 in a Japanese case.

Yoshikawa K, Kuwahara M, Saigoh K, Ishiura H, Yamagishi Y, Hamano Y, Samukawa M, Suzuki H, Hirano M, Mitsui Y, Tsuji S, Kusunoki S.

eNeurologicalSci. 2018 Nov 22;14:34-37. doi: 10.1016/j.ensci.2018.11.026. eCollection 2019 Mar.

41.

The relationship between the development of social competence and sleep in infants: a longitudinal study.

Tomisaki E, Tanaka E, Watanabe T, Shinohara R, Hirano M, Onda Y, Mochizuki Y, Yato Y, Yamakawa N, Anme T; Japan Children’s Study Group.

Child Adolesc Psychiatry Ment Health. 2018 Dec 18;12:53. doi: 10.1186/s13034-018-0258-8. eCollection 2018.

42.

Cancer Immunity and Gene Expression Data: A Quick Tool for Immunophenotype Evaluation.

Hirano M.

Cancer Res. 2018 Dec 1;78(23):6536-6538. doi: 10.1158/0008-5472.CAN-18-3288.

PMID:
30509957
43.

Different risk factors between early and late cancer recurrences in patients without additional surgery after noncurative endoscopic submucosal dissection for early gastric cancer.

Yamada S, Hatta W, Shimosegawa T, Takizawa K, Oyama T, Kawata N, Takahashi A, Oka S, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M, Nakaya N, Gotoda T.

Gastrointest Endosc. 2019 May;89(5):950-960. doi: 10.1016/j.gie.2018.11.015. Epub 2018 Nov 19.

PMID:
30465769
44.

18 F-Labeled Derivatives of Irbesartan for Angiotensin II Receptor PET Imaging.

Hoffmann M, Chen X, Hirano M, Arimitsu K, Kimura H, Higuchi T, Decker M.

ChemMedChem. 2018 Dec 6;13(23):2546-2557. doi: 10.1002/cmdc.201800638. Epub 2018 Nov 15.

PMID:
30430750
45.

Proteinase-activated receptor 1 antagonism ameliorates experimental pulmonary hypertension.

Kuwabara Y, Tanaka-Ishikawa M, Abe K, Hirano M, Hirooka Y, Tsutsui H, Sunagawa K, Hirano K.

Cardiovasc Res. 2019 Jul 1;115(8):1357-1368. doi: 10.1093/cvr/cvy284.

PMID:
30423156
46.

Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.

Sakurai K, Suda H, Fujie S, Takeichi T, Okuda A, Murao T, Hasuda K, Hirano M, Ito K, Tsuruta K, Hattori M.

Dig Dis Sci. 2019 Mar;64(3):815-822. doi: 10.1007/s10620-018-5365-0. Epub 2018 Nov 10. Erratum in: Dig Dis Sci. 2019 Feb 28;:.

47.

Discordance between subjective and objective evaluations of cognitive function in old Japanese patients with heart failure.

Saito H, Matsue Y, Suzuki M, Kamiya K, Hasegawa Y, Endo Y, Negishi Y, Hirano M, Takanashi K, Iizuka H, Matsumura A, Hashimoto Y.

Australas J Ageing. 2019 Mar;38(1):57-59. doi: 10.1111/ajag.12591. Epub 2018 Oct 14.

PMID:
30318779
48.

Novel 18F-Labeled PET Imaging Agent FV45 Targeting the Renin-Angiotensin System.

Chen X, Hirano M, Werner RA, Decker M, Higuchi T.

ACS Omega. 2018 Sep 30;3(9):10460-10470. doi: 10.1021/acsomega.8b01885. Epub 2018 Sep 4.

49.

Cardiomyopathy and altered integrin-actin signaling in Fhl1 mutant female mice.

Kubota A, Juanola-Falgarona M, Emmanuele V, Sanchez-Quintero MJ, Kariya S, Sera F, Homma S, Tanji K, Quinzii CM, Hirano M.

Hum Mol Genet. 2019 Jan 15;28(2):209-219. doi: 10.1093/hmg/ddy299.

PMID:
30260394
50.

Embedding of lamellar hole-associated epiretinal proliferation combined with internal limiting membrane inversion for the treatment of lamellar macular hole: a case report.

Shiode Y, Morizane Y, Takahashi K, Kimura S, Hosokawa M, Hirano M, Doi S, Toshima S, Hosogi M, Fujiwara A, Shiraga F.

BMC Ophthalmol. 2018 Sep 24;18(1):257. doi: 10.1186/s12886-018-0926-8.

Supplemental Content

Loading ...
Support Center